Diagnostics Savara Highlights IMPALA-2 Trial Success for Rare Lung Disease at ATS 2025 Posted on 3 weeks ago —by Salil Urunkar Savara is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. Read More